Clinical trial Recruiting at 1 site Interventional Women only

Education for first-time pregnant women with fear of childbirth

Official title: The Effects of Education Given to Primiparous Pregnant Women Who Have Fear of Childbirth According to Joyce Travelbee's Human-to-Human Relationship Model on Fear of Childbirth, Readiness for Childbirth and Acceptance of the Maternal Role

Run by Hasan Kalyoncu University · NCT06947369 · Data updated 2026-11-12

This study is testing if educational support can help first-time pregnant women who are afraid of childbirth feel more prepared and confident about becoming mothers.

More Pregnant Woman trials

Quick facts

Study typeInterventional
SexWomen only
Enrollment70 (estimated)
SponsorHasan Kalyoncu University
Academic / other
Locations1 site (Kilis, Merkez)
StatusRecruiting
StartedMarch 3, 2025
Main results expectedJune 2025
Study endsJuly 31, 2025
Registry record updatedApril 27, 2025
Trial IDNCT06947369 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are first-time pregnant women between 28-40 weeks of gestation who experience a moderate to high level of fear regarding childbirth.

Probably not a fit

Patients who may not benefit from this study include those with chronic health issues, high-risk pregnancies, or those who have received infertility treatment.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to evaluate the effects of educational interventions based on Joyce Travelbee's Human-to-Human Relationship Model on first-time pregnant women experiencing fear of childbirth. Conducted as a randomized controlled experimental study, it will involve collecting data from participants at Kilis Prof.Dr.Alaeddin Yavaşca State Hospital between March and July 2025. The study will assess changes in fear of childbirth, readiness for childbirth, and acceptance of the maternal role among the participants. Various assessment tools, including the Wijma Birth Anticipation/Experience Scale, will be utilized to measure outcomes.

Why it matters

Potential benefit: If successful, this intervention could significantly reduce fear of childbirth and improve maternal readiness and acceptance of the maternal role for first-time mothers.

How similar studies have gone: Other studies have shown positive outcomes with educational interventions for pregnant women, suggesting that this approach may be effective.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:1. The pregnant woman's first pregnancy. 2. A mid-level or above score on the Wijma Childbirth Expectation/Experience Scale Version A.

3\. The pregnant woman is between 28-40 weeks of gestation (third trimester). 4. The pregnant woman does not have a chronic health problem. 5. The pregnant woman has a single fetus. 6. The pregnant woman has not received infertility treatment. 7. The pregnant woman has not received a psychiatric diagnosis. 8. The pregnant woman does not have a high-risk pregnancy. 9. The pregnant woman's acceptance to participate in the study.

Exclusion Criteria:1. Not willing to participate in the study 2. Not speaking Turkish 3. Illiterate, having communication difficulties 4. Not meeting the study criteria

\-

Where it's running

  • Kilis Prof.Dr.Alaeddin Yavaşca State Hospital
    Kilis, Merkez, Turkey (Türkiye)
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.